H. pylori Test Strips

WhatsApp Order

H. pylori Test Strips are rapid, lateral flow immunochromatographic devices used for the qualitative detection of Helicobacter pylori antigens in human stool. As a non-invasive stool antigen test (SAT), it provides a convenient and reliable method for diagnosing active H. pylori infection and confirming eradication after therapy, with results available in under 15 minutes. Ideal for use in clinics and outpatient settings, it aids in the management of dyspepsia and peptic ulcer disease. Proper sample handling, adherence to pre-test medication restrictions, and strict biohazard precautions are essential for obtaining accurate results.

Categories: DIAGNOSTIC EQUIPMENT, CONSUMABLES AND DISPOSABLES, Diagnostic Kits Tags: DiagnosticStrips, GastrointestinalDiagnostic, HelicobacterPylori, HpyloriTest, PointOfCareTest, RapidTestKit, StoolAntigenTest

Description

H. pylori Test Strips

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Point-of-Care Screening for Helicobacter pylori Infection:

Primary Use: The primary use is for the rapid, qualitative detection of specific antigens from Helicobacter pylori in human stool samples. It serves as a convenient, non-invasive screening tool to identify current active infection in patients with symptoms of dyspepsia, gastritis, or peptic ulcer disease.
How it helps: Provides doctors with a simple, non-invasive way to check for a common cause of stomach pain, bloating, and ulcers, allowing treatment to begin quickly without subjecting patients to uncomfortable procedures.

2. Non-Invasive Diagnosis in Pediatric and Adult Patients:

Primary Use: Particularly useful for patients who cannot or prefer not to undergo invasive procedures like endoscopy and biopsy (the gold standard). It is well-suited for children and for initial workup in primary care settings.
How it helps: Spares children and anxious adults from the stress and discomfort of endoscopic procedures, offering a gentle, stool-based test that is much easier for patients of all ages to tolerate.

3. Confirmation of Eradication Post-Treatment:

Primary Use: A key application is to confirm the success of H. pylori eradication therapy. A follow-up test is typically performed at least 4 weeks after completion of antibiotic and proton pump inhibitor (PPI) treatment to verify that the infection has been cleared.
How it helps: Provides patients and their doctors with clear evidence that the course of antibiotics worked, offering peace of mind that the bacteria has been eliminated and reducing the risk of ulcer recurrence or complications.

4. Epidemiological and Public Health Studies:

Primary Use: Used in community health settings and research to estimate the prevalence of H. pylori infection in populations.
How it helps: Helps public health officials understand how common this infection is in different communities, guiding efforts to reduce its spread and associated health problems like stomach cancer.

SECONDARY & SUPPORTIVE USES

1. Monitoring High-Risk Groups: Screens individuals with a family history of gastric cancer or those on long-term NSAID therapy who may be at increased risk for H. pylori-related complications, catching infections early when they are easiest to treat.

2. Triaging Patients for Endoscopy: A positive stool antigen test in a symptomatic patient provides a strong indication for upper gastrointestinal endoscopy to assess for ulcers, gastritis, or other pathology, helping doctors prioritize which patients need invasive procedures.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Rapid, Immunochromatographic, Lateral Flow Assay.
Common Name: H. pylori Stool Antigen Test (SAT).
Sample Type: Fresh human stool sample. Some kits may also be validated for use with stool samples stored in specific transport media.
Target: Detects H. pylori antigens (proteins), specifically indicating an active, current infection (as opposed to antibody tests which can remain positive after past infection).

2. TECHNICAL & PERFORMANCE PROPERTIES

Test Principle: Utilizes monoclonal or polyclonal antibodies specific to H. pylori antigens. The stool sample is mixed with an extraction buffer. When this mixture is applied to the test device, it migrates laterally. If H. pylori antigens are present, they bind to antibody-colored conjugate particles, forming a visible colored line in the test region (T).
Procedure: A small stool sample is collected and mixed with the provided extraction buffer. Several drops of the mixture are then added to the sample well of the test cassette. Results are read after 5-15 minutes.
Interpretation:
- Positive: Two colored lines appear—one in the Control line region (C) and one in the Test line region (T).
- Negative: Only one colored line appears in the Control line region (C). No line appears in the Test line region.
- Invalid: No line appears in the Control region. The test must be repeated with a new device.
Accuracy: Performance must meet regulatory standards. Sensitivity and specificity are typically >90% when compared to reference methods (histology, urea breath test). Exact figures are kit-dependent and should be verified from the product insert.
Time to Result: Results are available in 5 to 15 minutes.

3. PHYSICAL & OPERATIONAL PROPERTIES

Kit Format: Sold as a complete test kit, usually containing:
- Test cassettes or strips (individually sealed in foil pouches with desiccant).
- Sample collection devices (spatula, tube).
- Extraction buffer vials.
- Disposable droppers.
- Instructions for Use (IFU).
Storage: Most kits require storage at room temperature (2-30°C). Must be kept in a dry place and protected from direct sunlight and freezing. Always check the expiry date before use.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: Must carry relevant medical device approvals: CE Marking (for EU), FDA 510(k) Clearance (for US), and other national regulatory approvals.
Quality Standards: Manufactured under a ISO 13485 quality management system.
Intended Use: Approved for professional use in clinics, laboratories, or for prescription home use with proper instructions.

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store unopened test kits at the temperature specified by the manufacturer (usually room temperature). Do not use expired kits.
Stool Sample Handling: Stool samples should be tested as soon as possible after collection (ideally within 24 hours if refrigerated at 2-8°C). Some kits provide specific transport media for longer stability.
Waste Disposal: The used test device, sample collection materials, and gloves should be disposed of as biohazardous waste following local regulations.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: A rapid, non-invasive screening and diagnostic tool for active H. pylori infection, suitable for use in outpatient clinics, physician offices, and smaller laboratories.
Important Consideration: Proton Pump Inhibitors (PPIs), antibiotics, and bismuth compounds can suppress bacterial load and lead to false-negative results. Patients should ideally stop PPIs for 2 weeks and antibiotics/bismuth for 4 weeks prior to testing.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Biohazard Precautions: Stool samples are potential sources of infection. Perform testing wearing appropriate Personal Protective Equipment (PPE): disposable gloves, lab coat, and safety glasses if splashing is possible.
Avoid Contamination: Do not touch the sample window (membrane) of the test cassette. Use the provided dropper for sample application.
Follow Instructions Precisely: Adhere strictly to the incubation times and sample preparation steps in the IFU. Adding too much or too little sample can affect the result.
Interpretation Window: Read results within the specified time frame (e.g., at 10 minutes). Do not interpret results after 20-30 minutes, as an evaporation line may appear and be misinterpreted as positive.

2. FIRST AID MEASURES

Ingestion: If any kit components (buffer, test device) are ingested, seek medical advice and provide the product information.
Skin/Eye Contact: If extraction buffer contacts skin or eyes, rinse immediately with plenty of water for several minutes. If irritation persists, seek medical advice.

3. FIRE FIGHTING MEASURES

Flammability: The plastic cassette, paper components, and packaging are combustible.
Extinguishing Media: Use water, foam, or CO₂ as appropriate for the surrounding fire.

H. pylori Test Strips

H. pylori Test Strips

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Point-of-Care Screening for Helicobacter pylori Infection:

How it helps: Provides doctors with a simple, non-invasive way to check for a common cause of stomach pain, bloating, and ulcers, allowing treatment to begin quickly without subjecting patients to uncomfortable procedures.

2. Non-Invasive Diagnosis in Pediatric and Adult Patients:

Primary Use: Particularly useful for patients who cannot or prefer not to undergo invasive procedures like endoscopy and biopsy (the gold standard). It is well-suited for children and for initial workup in primary care settings.

How it helps: Spares children and anxious adults from the stress and discomfort of endoscopic procedures, offering a gentle, stool-based test that is much easier for patients of all ages to tolerate.

3. Confirmation of Eradication Post-Treatment:

Primary Use: A key application is to confirm the success of H. pylori eradication therapy. A follow-up test is typically performed at least 4 weeks after completion of antibiotic and proton pump inhibitor (PPI) treatment to verify that the infection has been cleared.

How it helps: Provides patients and their doctors with clear evidence that the course of antibiotics worked, offering peace of mind that the bacteria has been eliminated and reducing the risk of ulcer recurrence or complications.

4. Epidemiological and Public Health Studies:

Primary Use: Used in community health settings and research to estimate the prevalence of H. pylori infection in populations.

How it helps: Helps public health officials understand how common this infection is in different communities, guiding efforts to reduce its spread and associated health problems like stomach cancer.

SECONDARY & SUPPORTIVE USES

1. Monitoring High-Risk Groups: Screens individuals with a family history of gastric cancer or those on long-term NSAID therapy who may be at increased risk for H. pylori-related complications, catching infections early when they are easiest to treat.

2. Triaging Patients for Endoscopy: A positive stool antigen test in a symptomatic patient provides a strong indication for upper gastrointestinal endoscopy to assess for ulcers, gastritis, or other pathology, helping doctors prioritize which patients need invasive procedures.

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Rapid, Immunochromatographic, Lateral Flow Assay.

Common Name: H. pylori Stool Antigen Test (SAT).

Sample Type: Fresh human stool sample. Some kits may also be validated for use with stool samples stored in specific transport media.

Target: Detects H. pylori antigens (proteins), specifically indicating an active, current infection (as opposed to antibody tests which can remain positive after past infection).

2. TECHNICAL & PERFORMANCE PROPERTIES

Procedure: A small stool sample is collected and mixed with the provided extraction buffer. Several drops of the mixture are then added to the sample well of the test cassette. Results are read after 5-15 minutes.

Interpretation:

Positive: Two colored lines appear—one in the Control line region (C) and one in the Test line region (T).

Negative: Only one colored line appears in the Control line region (C). No line appears in the Test line region.

Invalid: No line appears in the Control region. The test must be repeated with a new device.

Accuracy: Performance must meet regulatory standards. Sensitivity and specificity are typically >90% when compared to reference methods (histology, urea breath test). Exact figures are kit-dependent and should be verified from the product insert.

Time to Result: Results are available in 5 to 15 minutes.

3. PHYSICAL & OPERATIONAL PROPERTIES

Kit Format: Sold as a complete test kit, usually containing:

Test cassettes or strips (individually sealed in foil pouches with desiccant).

Sample collection devices (spatula, tube).

Extraction buffer vials.

Disposable droppers.

Instructions for Use (IFU).

Storage: Most kits require storage at room temperature (2-30°C). Must be kept in a dry place and protected from direct sunlight and freezing. Always check the expiry date before use.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: Must carry relevant medical device approvals: CE Marking (for EU), FDA 510(k) Clearance (for US), and other national regulatory approvals.

Quality Standards: Manufactured under a ISO 13485 quality management system.

Intended Use: Approved for professional use in clinics, laboratories, or for prescription home use with proper instructions.

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store unopened test kits at the temperature specified by the manufacturer (usually room temperature). Do not use expired kits.

Stool Sample Handling: Stool samples should be tested as soon as possible after collection (ideally within 24 hours if refrigerated at 2-8°C). Some kits provide specific transport media for longer stability.

Waste Disposal: The used test device, sample collection materials, and gloves should be disposed of as biohazardous waste following local regulations.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: A rapid, non-invasive screening and diagnostic tool for active H. pylori infection, suitable for use in outpatient clinics, physician offices, and smaller laboratories.

Important Consideration: Proton Pump Inhibitors (PPIs), antibiotics, and bismuth compounds can suppress bacterial load and lead to false-negative results. Patients should ideally stop PPIs for 2 weeks and antibiotics/bismuth for 4 weeks prior to testing.

1. SAFETY PRECAUTIONS

Biohazard Precautions: Stool samples are potential sources of infection. Perform testing wearing appropriate Personal Protective Equipment (PPE): disposable gloves, lab coat, and safety glasses if splashing is possible.

Avoid Contamination: Do not touch the sample window (membrane) of the test cassette. Use the provided dropper for sample application.

Follow Instructions Precisely: Adhere strictly to the incubation times and sample preparation steps in the IFU. Adding too much or too little sample can affect the result.

Interpretation Window: Read results within the specified time frame (e.g., at 10 minutes). Do not interpret results after 20-30 minutes, as an evaporation line may appear and be misinterpreted as positive.

2. FIRST AID MEASURES

Ingestion: If any kit components (buffer, test device) are ingested, seek medical advice and provide the product information.

Skin/Eye Contact: If extraction buffer contacts skin or eyes, rinse immediately with plenty of water for several minutes. If irritation persists, seek medical advice.

3. FIRE FIGHTING MEASURES

Flammability: The plastic cassette, paper components, and packaging are combustible.

Extinguishing Media: Use water, foam, or CO₂ as appropriate for the surrounding fire.

Related products

BRANDS

FOLLOW US